Scarica l'app Stockscreener
137.27
3.70%
4.60
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMDX Giù?
Forum
Previsione
Precedente Chiudi:
$132.67
Aprire:
$132.8
Volume 24 ore:
609.87K
Relative Volume:
0.72
Capitalizzazione di mercato:
$4.69B
Reddito:
$531.29M
Utile/perdita netta:
$71.66M
Rapporto P/E:
70.98
EPS:
1.9338
Flusso di cassa netto:
$17.35M
1 W Prestazione:
+13.09%
1M Prestazione:
+0.78%
6M Prestazione:
+9.92%
1 anno Prestazione:
+74.88%
Intervallo 1D:
$131.00
$138.60
Intervallo di 1 settimana:
$120.17
$138.60
Portata 52W:
$55.00
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Nome
Transmedics Group Inc
Settore
Industria
Telefono
(978) 552-0900
Indirizzo
200 MINUTEMAN ROAD, ANDOVER, MA
Confronta TMDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
137.28 | 4.53B | 531.29M | 71.66M | 17.35M | 1.9338 |
|
ABT
Abbott Laboratories
|
127.08 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.65 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.92 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.81 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.78 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Aggiornamento | Needham | Hold → Buy |
| 2025-10-13 | Iniziato | Jefferies | Buy |
| 2025-09-16 | Iniziato | Evercore ISI | Outperform |
| 2025-09-04 | Iniziato | Stifel | Hold |
| 2024-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Downgrade | Needham | Buy → Hold |
| 2024-10-29 | Reiterato | Needham | Buy |
| 2024-10-29 | Reiterato | Oppenheimer | Outperform |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-08-21 | Iniziato | Needham | Buy |
| 2024-06-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Iniziato | Stephens | Overweight |
| 2024-03-28 | Iniziato | Piper Sandler | Overweight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2022-08-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2019-05-28 | Iniziato | Canaccord Genuity | Buy |
| 2019-05-28 | Iniziato | Cowen | Outperform |
| 2019-05-28 | Iniziato | JP Morgan | Overweight |
| 2019-05-28 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Transmedics Group Inc Borsa (TMDX) Ultime notizie
Why TransMedics Group Inc. stock could outperform in 2025Sector Performance Drivers & Next-Level Stock Intelligence, Now Free - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Stifel maintains Hold rating on TransMedics stock amid slowing growth By Investing.com - Investing.com UK
Here's why TransMedics (TMDX) is a strong growth stock - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Trading the Move, Not the Narrative: (TMDX) Edition - Stock Traders Daily
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
TransMedics (TMDX) Sees Modest Growth in Transplant Volumes and Revenue Prospects - GuruFocus
How Is The Market Feeling About TransMedics Group Inc? - Benzinga
Piper Sandler reiterates Overweight rating on TransMedics stock By Investing.com - Investing.com Canada
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Some Confidence Is Lacking In TransMedics Group, Inc.'s (NASDAQ:TMDX) P/E - 富途牛牛
Here's Why TransMedics Group (NASDAQ:TMDX) Can Manage Its Debt Responsibly - simplywall.st
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Eastern Progress
Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More - Benzinga
TransMedics Group (NASDAQ:TMDX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Here Are My Top 2 No-Brainer Growth Stocks to Buy Now - The Globe and Mail
Here's Why TransMedics (TMDX) is a Strong Growth Stock - Yahoo Finance
TMDX INVESTORS: Kirby McInerney LLP Reminds TransMedics Group, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm - TMX Newsfile
Aug Breakouts: Is TransMedics Group Inc. stock dividend yield sustainableJuly 2025 Intraday Action & Weekly High Return Forecasts - moha.gov.vn
New TransMedics hires get stock options and units with long vesting - Stock Titan
TransMedics Stock: I Estimate An Upside Of Nearly 150% By The End Of 2028 (NASDAQ:TMDX) - Seeking Alpha
TransMedics Could Report Q4 Beat if it Maintains Monthly Organ Transplant Volume, Needham Says - marketscreener.com
TransMedics: A Stagnant Monopoly Facing Regulatory Pressure (NASDAQ:TMDX) - Seeking Alpha
Behavioral Patterns of TMDX and Institutional Flows - Stock Traders Daily
TransMedics stock could see upside from heart trial, Piper Sandler says - Investing.com Canada
Zevenbergen Capital Investments LLC Increases Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat
Texas Permanent School Fund Corp Purchases 12,249 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics Group (NASDAQ:TMDX) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Growth Review: Is TransMedics Group Inc. stock dividend yield sustainable2025 Winners & Losers & Free Technical Pattern Based Buy Signals - Улправда
Market Leaders: Will TransMedics Group Inc. stock recover faster than peersNew Guidance & Safe Entry Trade Signal Reports - Улправда
Is TransMedics Group Inc. stock affected by interest rate hikesJuly 2025 Intraday Action & Accurate Intraday Trade Tips - DonanımHaber
Will TransMedics Group Inc. stock rally after Fed decisionsEarnings Trend Report & Risk Controlled Swing Alerts - DonanımHaber
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026 - Zacks Investment Research
Canaccord Genuity Maintains TransMedics Group (TMDX) Buy Recommendation - Nasdaq
TransMedics Group (NASDAQ:TMDX) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
TransMedics Group (TMDX): Canaccord Genuity Raises Price Target | TMDX Stock News - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Boston Scientific (BSX), TransMedics Group (TMDX) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt? - 富途牛牛
Is TransMedics Group, Inc.'s (NASDAQ:TMDX) ROE Of 26% Impressive? - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Liontrust Investment Partners LLP Reduces Stake in TransMedics Group, Inc. $TMDX - MarketBeat
Eventide Asset Management LLC Sells 130,626 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
Braidwell LP Cuts Stock Holdings in TransMedics Group, Inc. $TMDX - MarketBeat
Bellevue Group AG Reduces Stake in TransMedics Group, Inc. $TMDX - MarketBeat
(TMDX) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
2025-12-11 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation | NDAQ:TMDX | Press Release - Stockhouse
Reasons to retain TransMedics stock in your portfolio for now - MSN
2 under-the-radar stocks that have soared this year - MSN
Transmedics Group Inc Azioni (TMDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Transmedics Group Inc Azioni (TMDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Weill David | Director |
Dec 03 '25 |
Sale |
138.64 |
5,000 |
693,200 |
12,134 |
| Hernandez Gerardo | Chief Financial Officer |
Dec 04 '25 |
Sale |
139.62 |
920 |
128,450 |
15,064 |
1.20%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):